Zacks Research lowered shares of Schrodinger (NASDAQ:SDGR – Free Report) from a strong-buy rating to a hold rating in a research report sent to investors on Tuesday,Zacks reports.
Several other research firms have also commented on SDGR. TD Cowen upped their target price on Schrodinger from $20.00 to $31.00 and gave the company a “buy” rating in a report on Tuesday, October 13th. Weiss Ratings raised Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 27th. KeyCorp boosted their price objective on Schrodinger from $20.00 to $32.00 and gave the company an “overweight” rating in a research report on Friday, October 16th. UBS Group upped their price objective on Schrodinger from $19.00 to $21.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 20th. Finally, Wall Street Zen raised Schrodinger from a “strong sell” rating to a “hold” rating in a research report on Saturday, August 8th. Four analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $25.83.
Check Out Our Latest Research Report on SDGR
Schrodinger Stock Performance
Shares of NASDAQ:SDGR opened at $28.52 on Tuesday. The company’s fifty day moving average is $25.43 and its two-hundred day moving average is $16.95. Schrodinger has a 1-year low of $10.94 and a 1-year high of $33.78. The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of -38.54 and a beta of 1.69.
Schrodinger (NASDAQ:SDGR – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported ($0.50) EPS for the quarter, beating the consensus estimate of ($0.67) by $0.17. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The business had revenue of $64.49 million during the quarter, compared to analyst estimates of $47.73 million. During the same period in the previous year, the business posted ($0.45) EPS. The company’s quarterly revenue was up 18.7% on a year-over-year basis. Sell-side analysts expect that Schrodinger will post -1.50 EPS for the current fiscal year.
Insider Transactions at Schrodinger
In related news, insider Karen Akinsanya sold 31,599 shares of the firm’s stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $29.37, for a total value of $928,062.63. Following the sale, the insider directly owned 69,956 shares in the company, valued at $2,054,607.72. This trade represents a 31.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.10% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in SDGR. Fulcrum Asset Management LLP lifted its position in Schrodinger by 1,509.3% in the third quarter. Fulcrum Asset Management LLP now owns 3,476 shares of the company’s stock worth $105,000 after purchasing an additional 3,260 shares during the period. Pictet Asset Management Holding SA acquired a new position in shares of Schrodinger during the 3rd quarter valued at $332,000. Calamos Advisors LLC acquired a new position in shares of Schrodinger during the 3rd quarter valued at $1,864,000. Commonwealth Equity Services LLC acquired a new position in shares of Schrodinger during the 3rd quarter valued at $317,000. Finally, ProShare Advisors LLC bought a new stake in shares of Schrodinger in the 3rd quarter worth $246,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
About Schrodinger
Schrödinger, Inc develops computational software and services designed to support pharmaceutical, biotechnology and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists analyze molecular interactions, design compounds and prioritize candidates for experimental testing.
The company’s software offerings include tools for molecular modeling, quantum chemistry, molecular dynamics, virtual screening, property prediction and free-energy calculations.
Further Reading
- Five stocks we like better than Schrodinger
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
